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Abstract 
 
Both ADHD and COMT genotype have been linked to altered dopaminergic transmission and 
possible impairment in frontal lobe functioning. This study offers an investigation of a 
possible interaction between ADHD diagnosis and COMT genotype on measures of working 
memory and executive function. Thirty-five adults with ADHD, who were recruited from the 
ADHD outpatient clinic at the Department of Psychiatry, Psychosomatics and Psychotherapy, 
University of Würzburg, and thirty-five matched healthy controls completed the Digit Span 
test and the Stroop Color Word Test. While there were no main effects of ADHD or COMT, 
the two factors interacted on both Digit Span subtests, with the two groups’ met/met carriers 
showing significantly different performance on the Digit Span Forward subtest and the val/val 
carriers showing significantly different performance on the Digit Span Backward subtest. 
Findings provide preliminary support for a differential impact of COMT genotype on working 
memory measures in adult patients with ADHD compared to healthy controls.  
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Introduction 
Attention deficit/hyperactivity disorder (ADHD) is known to impair the regulation of activity, 
behavioral impulses, and attention as well as various higher order cognitive processes like 
inhibitory control (Boonstra, Oosterlaan, Sergeant, & Buitelaar, 2005) and working memory 
(Barkley, 1997; Martinussen, Hayden, Hogg-Johnson, & Tannock, 2005; Willcutt, Doyle, 
Nigg, Faraone, & Pennington, 2005). Etiological models link ADHD to abnormalities in 
corticostriatal dopaminergic circuits (Sonuga-Barke, 2005). Neuroimaging findings support 
these theories by showing altered dopamine turnover in the striatum of ADHD patients, with 
methylphenidate – a medication known to counteract symptoms of ADHD – acting in the 
striatum by blocking dopamine re-uptake and thereby increasing synaptic dopamine levels 
(Krause, Dresel, Krause, Kung, & Tatsch, 2000; Krause, Dresel, Krause, la Fougere, & 
Ackenheil, 2003).  
The gene coding the enzyme catechol-O-methyltransferase (COMT), which degrades 
neurotransmitters such as dopamine (Axelrod, 1957), has previously been studied as a 
potential candidate gene for ADHD and for possible neuropsychological phenotypes with 
conflicting results (Caylak, 2012; Kebir & Joober, 2011; Kebir, Tabbane, Sengupta, & Joober, 
2009). Due to the low expression of the dopamine transporter in the prefrontal cortex, the 
COMT enzyme plays a critical role in clearing dopamine from the synaptic cleft in this area 
(Dickinson & Elvevag, 2009; Lewis et al., 2001; Lewis, Sesack, Levey, & Rosenberg, 1997; 
Meyer-Lindenberg & Weinberger, 2006; Tunbridge, Bannerman, Sharp, & Harrison, 2004). 
Furthermore, the activity of COMT has been hypothesized to influence striatal dopamine 
levels by acting on dopamine that has diffused from the synaptic cleft (Bilder, Volavka, 
Lachman, & Grace, 2004). Within the COMT gene, a functional single nucleotide 
polymorphism (rs4680) causes a valine (val) to methionine (met) substitution at codon 158 
(val158met) (Lachman et al., 1996), which leads to COMT isoforms that differ greatly in 
thermolability (Lotta et al., 1995). Two met alleles lead to a three to four times lower activity 
of COMT compared to two val alleles, with heterozygosity leading to intermediate COMT 
activity (Chen et al., 2004; Weinshilboum, Otterness, & Szumlanski, 1999).  
4 	  
According to the tonic-phasic model of subcortical dopaminergic functioning, the sustained 
tonic release of dopamine can regulate the intensity of the transient phasic dopaminergic 
response to relevant stimuli (Grace, 1991). In the cortex, the lower COMT activity associated 
with two met alleles has furthermore been hypothesized to lead to increased cortical 
dopamine concentrations and thus increased stimulation of D1 receptors (Bilder et al., 2004). 
This might result in increased stability of the neural networks underlying working memory 
functions in met/met carriers. In contrast, the lower concentrations of cortical dopamine 
caused by two val alleles should lead to increased D2 transmission and thus increased 
flexibility of these networks in val/val carriers (Bilder et al., 2004; Levy, 2007). 
The influence of the COMT polymorphism on higher order cognitive functioning was 
previously explored in behavioral studies: Healthy met/met carriers showed better 
performance on a letter-number-sequencing test (Bruder et al., 2005), an n-back task 
(Goldberg et al., 2003), and the Wisconsin Card Sorting Test (Egan et al., 2001) than val/val 
carriers, with val/met carriers usually performing in between. A recent meta-analysis showed 
a positive association of two met alleles with IQ score. Associations for n-back performance 
were less clear, with two met alleles being associated with better performance for patient 
populations but one val allele being associated with better performance for non-patient 
populations (Barnett, Scoriels, & Munafo, 2008). The clinical studies reviewed in this meta-
analysis examined the performance of schizophrenic patients. One of these studies found 
worse performance for all val/val carriers irrespective of diagnostic status (Diaz-Asper et al., 
2008), while the other study focused on fMRI activation and suspected a left-shift of the 
inverted-U response curve of schizophrenic patients, leading to less efficient prefrontal 
functioning (Bertolino et al., 2006).  
To our knowledge, only one study examined a sample of adults with ADHD to investigate the 
influence of COMT genotype on various measures of neurocognitive performance. This study 
found a positive association of the val/met genotype and full-scale IQ as assessed with the 
Wechsler Adult Intelligence Scale (WAIS) (Boonstra et al., 2008). The authors report no main 
effect of COMT genotype on the WAIS subtests Digit Span Forward or Digit Span Backward 
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or the Stroop Color Word Test. Two similar studies of children with ADHD found no effect of 
COMT genotype on performance on various measures of executive function (Mills et al., 
2004; Taerk et al., 2004). However, a third study reports a negative association of val/val 
genotype and a delayed-match-to-sample task in children (Matthews et al., 2012), while a 
fourth study with children found a negative association of the met allele and a measure of 
sustained attention (Bellgrove et al., 2005). Overall, studies of the impact of COMT in ADHD 
patients show greatly differing results. This heterogeneity of results might either be caused 
by the different types of working memory measures used in these studies (Matthews et al., 
2012), or it might point to an effect of COMT on cognition that is less robust than originally 
assumed. Our review of the literature yielded only one study that examined COMT genotype 
and neurocognitive performance in adult ADHD (aADHD) patients, while four studies 
investigated children and adolescents. None of the above-mentioned studies investigated a 
healthy control group.  
Our study included carefully diagnosed adult ADHD patients and a healthy control group 
comparable with regard to age, gender, and years of formal schooling. All participants 
completed neuropsychological measures of verbal short-term memory, verbal working 
memory, and inhibitory control. The aim was to preliminarily investigate whether a possible 
influence of COMT genotype on task performance interacted with participants’ ADHD 
diagnosis. The tasks were the same as in a previous study on aADHD and COMT (Boonstra 
et al., 2008). However, contrary to this study we also included a well-matched healthy control 
group to investigate possible interactive effects of these two factors. As COMT might 
influence performance on cognitive tasks across both patients and healthy controls, our 
study aimed to investigate whether adult patients with ADHD – a disorder known to affect 
dopaminergic transmission (Krause et al., 2000) – might be at an additional disadvantage 
caused by their COMT genotype. Furthermore, aADHD patients in our study were medication 
naïve or without medication for at least three months, meaning that any observed effects 
would likely not be induced by present stimulant treatment or the short-term discontinuation 
thereof.  
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Based on previous studies (Boonstra et al., 2005; Martinussen et al., 2005; Willcutt et al., 
2005), we expected aADHD patients to perform worse than healthy controls on all 
investigated measures of higher order cognitive functioning. Furthermore, according to the 
tonic-phasic model of dopaminergic functioning (Bilder et al., 2004; Grace, 1991), the COMT 
val allele should be more detrimental to aADHD patients than to healthy controls in a gene‐
dosage fashion, with val/val aADHD patients showing the worst performance.  
 
 
Methods 
Participants 
A total of 70 participants (thirty-five patients with ADHD and thirty-five healthy controls) of 
Caucasian ethnicity took part in a larger study that comprised fMRI measurements and 
neuropsychological assessments and were included in the analysis. The results of the fMRI 
measurements will be published elsewhere. Forty-one patients with aADHD were originally 
recruited from the ADHD outpatient clinic at the Department of Psychiatry, Psychosomatics, 
and Psychotherapy of the University of Würzburg. Of all recruited aADHD patients, three did 
not meet full inclusion criteria. Three more patients decided not to proceed with the study 
after inclusion. Diagnoses were made by an experienced psychiatrist according to DSM-IV-
TR (2000). Patients had to be medication naïve or without medication for at least three 
months prior to testing. Of the investigated sample, 29 % (10 patients) had previously been 
treated with methylphenidate and/or atomoxetine, and 11 % (4 patients) had previously been 
treated with an antidepressant or antipsychotic. For 7 patients, no data regarding previous 
psychopharmacological treatment could be obtained.  
To corroborate the initial diagnosis, all patients were administered the Wender-Reimherr-
Interview (WRI) (Corbisiero, Buchli-Kammermann, & Stieglitz, 2010), the Conners’ Adult 
ADHD Rating Scales (CAARS) (Conners, Erhardt, & Sparrow, 1999), and the Wender Utah 
Rating Scale (WURS) (Ward, Wender, & Reimherr, 1993). To assess possible comorbid axis 
I disorders (an exclusion criterion) and axis II disorders, all patients were assessed with the 
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Structured Clinical Interview for DSM-IV (SCID-I and SCID-II) (Wittchen, Zaudig, & Fydrich, 
1997), the Hamilton Depression Rating Scale (HAM-D) (Hamilton, 1960), and the Hamilton 
Anxiety Rating Scale (HAM-A) (Hamilton, 1959). Of the investigated sample, 17 % (6 
patients) fulfilled diagnostic criteria for an axis II disorder. Unfortunately, no reliable data 
regarding comorbid axis II disorders could be obtained for 4 of the investigated patients.  
Healthy controls without a past or present diagnosis of ADHD were recruited from a previously 
established sample (see also Biehl et al., 2013; Gschwendtner et al., 2012) as well as 
through university advertisement. All participants had normal or corrected-to-normal vision, 
and control participants were free of neurological or psychiatric diseases. A subset of 35 
healthy control participants was chosen from all recruited participants to match the patient group most 
closely in a case-control design (p > .1 for age, gender, and years of schooling; see table 1 for sample 
characteristics). All participants completed the Adult ADHD Self-Report Scale (ASRS) to obtain an 
estimate of any current ADHD-related symptomatology (Kessler et al., 2005)  
 
Table 1 Means and standard deviations (in parentheses) of the sample characteristics for the groups 
 
 
 
Healthy controls (HC) 
 
Group with ADHD 
Number of participants (male) 35 (16) 35 (20) 
Age  33.6 (9.6) 36.0 (9.9) 
School years 11.2 (1.8) 10.6 (1.6) 
Raw score Standard Progressive Matrices 49.0 (7.8) 49.1 (6.9) 
Inattentiona  11.5 (4.7)* 23.9 (5.2)* 
Hyperactivity/Impulsivitya  9.7 (5.8)* 19.1 (6.6)* 
Note. a Symptoms of inattention and hyperactivity/impulsivity as assessed with the ASRS (Kessler et 
al., 2005); * denotes significant between-group differences (p < .001) in two-tailed t-tests (df = 68) 
 
 
Procedure 
All participants completed the Digit Span subtest from the German version of the WAIS 
(Aster, Neubauer, & Horn, 2006). This test consists of increasingly long strings of 2 to 9 digits 
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(forward) or 2 to 8 digits (backward), which are read to the participants at a speed of one digit 
per second. The participant is then asked to repeat these digits back to the examiner, either 
in the presented order (Digit Span Forward) or in backward order (Digit Span Backward). If 
the participant can give the correct answer for at least one of two presented strings, the 
examiner moves on to the next longer string. The number of correctly repeated strings for 
each of the two subtests is used as performance measure.  
Participants also completed a German version of the Stroop Color Word Test (Bäumler, 
1985). This test comprises three different subtasks: Naming the color of color blocks, reading 
color words, and naming the color that was used to print color words (e.g. if the word “blue” is 
printed in red ink, the participant is required to say “red”). Each subtask is completed three 
times and the median completion times are used in the analysis. We analyzed the time for 
naming the color of color blocks as a measure of psychometric speed. The time for naming 
the color of color words was then divided by the psychometric speed to obtain a measure of 
inhibitory control.  
In addition, the Standard Progressive Matrices (Kratzmeier & Horn, 1988) were administered 
to obtain an estimate of intellectual functioning. All participants were genotyped for the 
COMT val158met polymorphism. Blood was taken and DNA was extracted using a standard 
de-salting procedure. A standard PCR procedure (slightly modified from the protocol used by 
Egan et al., 2001) was used to determine COMT genotypes, which did not deviate from 
Hardy-Weinberg equilibrium. Eighteen participants were genotyped as met/met (control 
group: 8; patient group: 10), thirty-five as val/met (control group: 17; patient group: 18), and 
seventeen as val/val (control group: 10; patient group: 7).  
 
Statistical Analysis 
Given the unequal cell sizes caused by the distribution of the COMT genotype in the general 
population, data were analyzed using a non-parametric equivalent of a two-way analysis of 
variance (ANOVA) that ranks observations for the levels of one factor within the levels of the 
other factor (Prescott & Shahlaee, 1999; Shirley, 1987). Number of correctly reproduced 
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strings in Digit Span Forward, number of correctly reproduced strings in Digit Span 
Backward, and the median time for naming the color of color words divided by psychometric 
speed each served as dependent variables. ADHD diagnosis and COMT genotype were 
entered as fixed factors in all analyses. Mann-Whitney-U tests for independent samples were 
used for post-hoc comparisons and Cohen’s d is reported to provide a measure of effect size 
for the post-hoc tests. For all analyses, p-values < .05 were considered significant.  
 
 
Results 
For Digit Span Forward (verbal short-term memory), we found no significant main effect of 
ADHD diagnosis (p = .16) or COMT genotype (p = .28). There was, however, a trend level 
interaction of ADHD diagnosis and COMT genotype (F(2,64) = 2.81, p = .07). Post-hoc tests 
revealed a significant difference between the two groups for carriers of the met/met genotype 
(p = .03, d = 1.0), with the group with ADHD performing significantly worse than the healthy 
control group (see figure 1; see table 2 for all means and standard deviations). There were 
no comparable differences for carriers of the val/met genotype (p = .25, d = 0.4) or the val/val 
genotype (p = .54, d = 0.3).  
 
Table 2 Means and standard deviations (in parentheses) of the neuropsychological tests, split by 
group and COMT genotype 
 
   
Digit Span: Forward 
 
Digit Span: Backward 
 
Stroop: Inhibitory Control 
H
C
 
Met/Met (8)a 11.0 (2.6)* 7.6 (2.9) 1.57 (0.20) 
Val/Met (17) 10.1 (1.4) 6.7 (1.6) 1.60 (0.18) 
Val/Val (10) 10.3 (2.3) 8.9 (2.3)* 1.58 (0.23) 
A
D
H
D
  
Met/Met (10) 8.5 (2.4)* 6.9 (2.5) 1.67 (0.17) 
Val/Met (18) 10.9 (2.1) 7.7 (2.3) 1.60 (0.18) 
Val/Val (7) 9.6 (2.0) 6.3 (1.8)* 1.52 (0.06) 
Note. a Number of participants per group; * denotes significant between-group differences (p < .05) 
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For Digit Span Backward (verbal working memory), we similarly found no significant main 
effect of ADHD diagnosis (p = .24) or COMT genotype (p = .85). However, there was a 
significant interaction of ADHD diagnosis and COMT genotype (F(2,64) = 3.27, p = .04). Post-
hoc tests revealed a significant difference between the two groups for carriers of the val/val 
genotype (p = .03, d = 1.3), with the group with ADHD performing significantly worse than the 
healthy control group (see figure 1). There were no comparable differences for carriers of the 
met/met genotype (p = .83, d = 0.3) or the val/met genotype (p = .37, d = 0.5) 
 
 
Figure 1 Mean number of correctly reproduced digit strings in the Digit Span Forward and in the Digit 
Span Backward subtest, for patients with ADHD and healthy controls and the different COMT 
genotypes. Error bars denote standard error of the mean (SEM). Significant between-group 
differences (p < .05) are marked by * 
 
For the Stroop Color Word Test (inhibitory control) we found neither a significant main effect 
of ADHD diagnosis (p = .64) nor COMT genotype (p = .37) nor a significant interaction 
(p = .40).  
 
 
Discussion 
This study aimed to investigate a possible interaction effect of COMT genotype and adult 
ADHD on different measures of working memory and executive function. A possible limitation 
of this investigation concerns the selection of the patient sample. As inclusion criteria were 
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rather strict, the obtained results might only apply to a subgroup of aADHD patients, who are 
still comparably well adjusted.  
A further limitation of this study is the small sample size for some of the cells. Caused by the 
distribution of the val and met alleles in Caucasian populations (Palmatier, Kang, & Kidd, 
1999), we investigated fewer homozygous than heterozygous participants. Especially for the 
homozygous participants, it is therefore possible that some other factor might have differed 
between the investigated groups and was not sufficiently counterbalanced, thus affecting the 
reported results. Although our results can therefore only be regarded as preliminary, we still 
found interaction effects of genotype and ADHD diagnosis on measures of verbal short-term 
memory and verbal working memory. Interestingly, the results show substantial effect sizes 
for a differential impact of COMT genotype and ADHD depending on the nature of the task: 
While met/met carriers with ADHD seemed to be at a disadvantage on the measure of verbal 
short-term memory compared to the other genotypes and healthy controls, val/val carriers 
with ADHD did not seem to profit in the same way as healthy val/val carriers on the measure 
of verbal working memory. There were no significant effects for the Stroop Color Word Test.  
This pattern of results is more complex than initially hypothesized. Still, our results can be 
interpreted in terms of the tonic-phasic model of increased stability or flexibility, depending on 
COMT genotype (Barnett et al., 2008; Bilder et al., 2004; Durstewitz & Seamans, 2008; 
Matthews et al., 2012): The measure of verbal short-term memory (Digit Span Forward) 
required the reproduction on increasingly long strings of numbers. It would therefore seem 
logical for met/met carriers to show better performance, as increased tonic dopamine – and 
thereby increased representational stability – would be advantageous in this task. However, 
compared to the healthy control group, the group with ADHD did not show this advantage. 
This finding is in line with another study that reported worse performance for met allele 
carriers with ADHD on a measure of sustained (i.e. stable) attention (Bellgrove et al., 2005). 
In contrast, the measure of verbal working memory (Digit Span Backward) required retention 
of lists of numbers as well as internal manipulation of these lists before reproduction. It could 
therefore be expected to favor val/val carriers as this genotype affords increased phasic 
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dopamine and thereby increased mental flexibility. Compared to healthy controls, patients 
with ADHD again did not show the expected advantage.  
To summarize, although we did not find main effects of COMT or ADHD on the investigated 
measures, two of the three tasks showed interactions of COMT genotype and ADHD 
diagnosis. Our results therefore point to a possible shift in the hypothesized inverted-U 
response curve of dopaminergic functioning in adults with ADHD compared to healthy 
controls (Bellgrove et al., 2005; Mattay et al., 2003). 
Given our relatively small overall sample size, the achieved power was certainly not sufficient 
to detect more subtle differences. These results do, however, point to the possibility of 
differential COMT effects in patients with ADHD compared to healthy controls. Given this 
effect of COMT in patients and in non-patients found in our study and also in the general 
COMT literature (Barnett et al., 2008), future patient studies would likely benefit from 
including healthy control groups.  
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